Brad Ansley's guest appearances

Brad Ansley

Business of Healthcare

David Nash

Omar Manejwala

Dale Owen

Rob LaHayne

Matt Monahan

Jay Graves

OwlTail

Digital is disrupting pharmaceutical companies at their very core: product development and commercial operations.  We explore this with two leaders deep in the thick of transforming this key healthcare segment . . . 10% of the overall healthcare spend in the US . . . as digital innovation destroys and recreates the industry.

Digital is disrupting pharmaceutical companies at their very core: product development and commercial operations.  We explore this with two leaders deep in the thick of transforming this key healthcare segment . . . 10% of the overall healthcare spend in the US . . . as digital innovation destroys and recreates the industry.

Are pharmaceutical makers becoming outcomes companies? with AJ Ploszay, Ph.D. (GlaxoSmithKline) Brad Ansley (SPI Health)

“No outcome, no income,” says Dr. David Nash, founding dean of the nation’s first graduate school of population health. He joins Brad Ansley of SPI Health to explore the emergence of population health and the implications for healthcare suppliers.  They cover the buyer’s perspective on changing health system needs, shared-risk contracting and new selling dynamics.

“No outcome, no income,” says Dr. David Nash, founding dean of the nation’s first graduate school of population health. He joins Brad Ansley of SPI Health to explore the emergence of population health and the implications for healthcare suppliers.  They cover the buyer’s perspective on changing health system needs, shared-risk contracting and new selling dynamics.

Population Health and the New Sales Paradigm.  Guests: David Nash & Brad Ansley

Empathy for the patient, helping providers improve efficiency, adjusting to new buying paradigms . . . the work and competencies of a sales representative is undergoing just as radical change as other stakeholders.  But do we even need salespeople in healthcare?  Is the portion of healthcare dollars spent on sales wasteful or productive? What drives a sales person and how can healthcare leaders ensure their organizations get the most value from these passionate contributors?  Filmed at eyeforpharma Philadelphia 2018#efpphilly @eyeforpharma

Empathy for the patient, helping providers improve efficiency, adjusting to new buying paradigms . . . the work and competencies of a sales representative is undergoing just as radical change as other stakeholders.  But do we even need salespeople in healthcare?  Is the portion of healthcare dollars spent on sales wasteful or productive? What drives a sales person and how can healthcare leaders ensure their organizations get the most value from these passionate contributors?  Filmed at <a href="http://www.eyeforpharma/philadelphia" rel="noopener nofollow" target="_blank">eyeforpharma Philadelphia 2018</a><a href="https://twitter.com/hashtag/efpphilly" rel="nofollow" target="_blank">#efpphilly </a><a href="https://twitter.com/eyeforpharma" rel="nofollow" target="_blank">@eyeforpharma</a>